Table 1.
Baseline characteristics of the whole study population and different sub-samples
| Variable | Total cohort (n=1052) | Without diabetes (n = 991) | Without diabetes, without metabolic syndrome (n = 824) | Without diabetes, without metabolic syndrome and normal weight (n=382) |
|---|---|---|---|---|
| Age (years) | 71.0±0.6 | 71.0±0.6 | 71.0±0.6 | 71.0±0.6 |
| Serum hsCRP (mg/l) | 3.3±4.7 | 3.3±4.8 | 3.2±4.8 | 3.1±5.1 |
| Serum IL-6 (ng/l) | 5.8±8.9 | 5.8±9.0 | 5.6±9.0 | 5.7±9.9 |
| Glucose disposal rate (M, mg/kg bw/min) | 5.3±2.0 | 5.4±2.0 | 5.8±1.8 | 6.6±1.7 |
| Fasting plasma glucose (mmol/l) | 5.5±1.0 | 5.4±0.6 | 5.3±0.5 | 5.2±0.5 |
| Systolic blood pressure (mmHg) | 147±19 | 146±18 | 145±18 | 144±18 |
| Diastolic blood pressure (mmHg) | 84±9 | 84±9 | 83±9 | 81±10 |
| Antihypertensive drugs | 353 (34) | 311 (31) | 235 (29) | 94 (25) |
| Serum HDL-cholesterol (mmol/l) | 1.3±0.3 | 1.3±0.3 | 1.4±0.3 | 1.4±0.4 |
| Serum triglycerides (mmol/l) | 1.4±0.7 | 1.4±0.7 | 1.2±0.5 | l.l±0.5 |
| Lipid lowering drugs | 91(9) | 86(9) | 73(9) | 36(9) |
| Diabetes mellitus | 61(6) | 0(0) | 0(0) | 0(0) |
| MetS (NCEP) | 210 (20) | 167 (17) | 0(0) | 0(0) |
| Body mass index (kg/m2) | 26.2±3.4 | 26.0±3.2 | 25.3±2.8 | 23.0±1.4 |
| Waist circumference (cm) | 94±9 | 94±9 | 92±8 | 87±6 |
| Smoking | 218 (21) | 208 (21) | 177 (21) | 91 (24) |
| Leisure time physical activity | ||||
| - sedentary | 36(4) | 31(3) | 22(3) | 8(2) |
| -moderate | 315 (33) | 294 (32) | 237 (31) | 103(29) |
| -regular | 545(57) | 524(58) | 448 (59) | 212 (60) |
| -athletic | 60(6) | 58(6) | 55(7) | 29(8) |
Date are mean±SD for continuous variables and n (%) for dichotomous variables, Metabolic syndrome (MetS) was defined using the ATP lll-NCEP-definition